Guggenheim Capital’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-10,622
Closed -$19K 2015
2022
Q3
$19K Sell
10,622
-67
-0.6% -$120 ﹤0.01% 1881
2022
Q2
$31K Sell
10,689
-615
-5% -$1.78K ﹤0.01% 2035
2022
Q1
$31K Sell
11,304
-34
-0.3% -$93 ﹤0.01% 2108
2021
Q4
$53K Buy
+11,338
New +$53K ﹤0.01% 2094